Closing Bell: Arch Biopartners Inc up on Friday (ARCH)

In trading today, Arch Biopartners Inc shares closed at $1.57 after opening the day at $1.60. Intraday prices ranged from $1.57 to $1.60.

The price boosted 0.64% from the previous day's close of $1.56.

During the day across North America, the TSX Composite closed -0.16% at 22690.39, the S&P 500 closed -0.78% at 5544.59, the Dow Jones Industrial Average closed -1.29% at 40665.02 and the Nasdaq Composite closed -0.70% at 17871.22.

Arch Biopartners Inc traded under ARCH on the Toronto Venture Exchange (TSX-V).

A total of 10,500 shares was traded during the session, with total trades of 18, while having an average volume of 17,583 in the last five days.

Trading across the entire TSX-V saw 1,821 price advancers against 3,352 declines and 121 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, the shares have shrunken -25.94 percent in the last 52 weeks, while they have advanced 6.08% this year.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $99.61 million on a float of 63,851 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Arch Biopartners Inc's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..